19-32996083-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_033103.5(RHPN2):c.1363G>A(p.Ala455Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000889 in 1,614,012 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_033103.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RHPN2 | NM_033103.5 | c.1363G>A | p.Ala455Thr | missense_variant | 11/15 | ENST00000254260.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RHPN2 | ENST00000254260.8 | c.1363G>A | p.Ala455Thr | missense_variant | 11/15 | 1 | NM_033103.5 | P1 | |
RHPN2 | ENST00000544458.6 | n.1692G>A | non_coding_transcript_exon_variant | 8/12 | 2 | ||||
RHPN2 | ENST00000585641.1 | n.379G>A | non_coding_transcript_exon_variant | 1/2 | 5 | ||||
RHPN2 | ENST00000588388.5 | c.*900G>A | 3_prime_UTR_variant, NMD_transcript_variant | 10/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000880 AC: 221AN: 251164Hom.: 0 AF XY: 0.000891 AC XY: 121AN XY: 135754
GnomAD4 exome AF: 0.000913 AC: 1334AN: 1461678Hom.: 2 Cov.: 32 AF XY: 0.000909 AC XY: 661AN XY: 727144
GnomAD4 genome AF: 0.000663 AC: 101AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000819 AC XY: 61AN XY: 74480
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at